Search the Community
Showing results for tags 'juvenile ssc research'.
Found 2 results
Diagnosis and management of linear scleroderma in children. Clinical evaluation, both physical exam and history, is the most important aspect in diagnosing and assessing activity of linear scleroderma. PubMed, Curr Opin Pediatr, 05/30/2019. (Also see Juvenile Scleroderma Research and Linear Scleroderma) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Fibrocell’s FX-013 Therapy Wins FDA Rare Pediatric Disease Designation for Localized Scleroderma. The U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to FX-013, a Fibrocell gene therapy candidate to treat children with moderate to severe localized scleroderma. Scleroderma News, 06/13/2017. (Also see Clinical Trials and Juvenile Scleroderma Research) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.